Fairmount Funds Management LLC Diversified Active

CIK: 0001802528 · Show all filings

Period: Q4 2025 (← Previous)

Filing Date: Feb 17, 2026

Total Value ($000): $1,313,784 (100.0% shares, 0.0% debt)

Holdings (13)

Increased Positions (5)

VRDN VIRIDIAN THERAPEUTICS INC 9.3%

Value ($000) $121,818 (+63.2%) Shares 3,914,458 (+13.1%) Est. Cost $17.81 Unrealized +54.0%

JBIO JADE BIOSCIENCES INC 5.3%

Value ($000) $70,260 (+152.8%) Shares 4,553,494 (+41.4%) Est. Cost $26.99 Unrealized -56.5%

ZBIO ZENAS BIOPHARMA INC 6.1%

Value ($000) $80,210 (+90.9%) Shares 2,209,025 (+16.7%) Est. Cost $20.11 Unrealized +63.5%

CBIO CRESCENT BIOPHARMA INC. 2.5%

Value ($000) $32,590 (+97.5%) Shares 2,747,866 (+98.0%) Est. Cost $16.99 Unrealized -25.0%

IKT INHIBIKASE THERAPEUTICS INC 1.3%

Value ($000) $17,681 (+78.2%) Shares 8,625,000 (+40.8%) Est. Cost $2.23 Unrealized -28.7%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
VRDN	VIRIDIAN THERAPEUTICS INC	3,914,458 (+13.1%)	$121,818 (+63.2%)	9.3%	$17.81	+54.0%	COM	92790C104
JBIO	JADE BIOSCIENCES INC	4,553,494 (+41.4%)	$70,260 (+152.8%)	5.3%	$26.99	-56.5%	COM NEW	008064206
ZBIO	ZENAS BIOPHARMA INC	2,209,025 (+16.7%)	$80,210 (+90.9%)	6.1%	$20.11	+63.5%	COM	98937L105
CBIO	CRESCENT BIOPHARMA INC.	2,747,866 (+98.0%)	$32,590 (+97.5%)	2.5%	$16.99	-25.0%	COM	G2545C104
IKT	INHIBIKASE THERAPEUTICS INC	8,625,000 (+40.8%)	$17,681 (+78.2%)	1.3%	$2.23	-28.7%	COM NEW	45719W205

Exited Positions (4)

AXSM AXSOME THERAPEUTICS INC 7.5%

Value ($000) $99,003 Shares 815,176 Est. Cost $49.79 Unrealized +180.4%

SRRK SCHOLAR ROCK HLDG CORP 5.2%

Value ($000) $67,927 Shares 1,824,031 Est. Cost $32.27 Unrealized +16.2%

ABVX ABIVAX SA 4.6%

Value ($000) $60,571 Shares 713,434 Est. Cost $84.90 Unrealized —

— ASTRIA THERAPEUTICS INC 2.0%

Value ($000) $25,874 Shares 3,554,129 Est. Cost $9.99 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
AXSM	AXSOME THERAPEUTICS INC	815,176	$99,003	7.5%	$49.79	+180.4%	—	05464T104
SRRK	SCHOLAR ROCK HLDG CORP	1,824,031	$67,927	5.2%	$32.27	+16.2%	—	80706P103
ABVX	ABIVAX SA	713,434	$60,571	4.6%	$84.90	—	—	00370M103
—	ASTRIA THERAPEUTICS INC	3,554,129	$25,874	2.0%	$9.99	—	—	04635X102

Decreased Positions (2)

DNTH DIANTHUS THERAPEUTICS INC 6.7%

Value ($000) $88,074 (-32.3%) Shares 2,137,191 (-35.4%) Est. Cost $17.22 Unrealized +125.2%

KNSA KINIKSA PHARMACEUTICALS INTL 4.1%

Value ($000) $54,437 (-20.9%) Shares 1,319,688 (-25.6%) Est. Cost $21.28 Unrealized +88.5%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
DNTH	DIANTHUS THERAPEUTICS INC	2,137,191 (-35.4%)	$88,074 (-32.3%)	6.7%	$17.22	+125.2%	COM	252828108
KNSA	KINIKSA PHARMACEUTICALS INTL	1,319,688 (-25.6%)	$54,437 (-20.9%)	4.1%	$21.28	+88.5%	ORD SHS CL A	G52694109

Unchanged Positions (6)

COGT COGENT BIOSCIENCES INC 24.3%

Value ($000) $319,801 Shares 9,003,418 Est. Cost $9.55 Unrealized +194.3%

APGE APOGEE THERAPEUTICS INC 11.8%

Value ($000) $154,632 Shares 2,048,647 Est. Cost $22.03 Unrealized +185.9%

SYRE SPYRE THERAPEUTICS INC 10.0%

Value ($000) $131,633 Shares 4,018,101 Est. Cost $31.80 Unrealized -17.8%

ORKA ORUKA THERAPEUTICS INC 8.5%

Value ($000) $112,306 Shares 3,705,262 Est. Cost $32.55 Unrealized -14.4%

ELVN ENLIVEN THERAPEUTICS INC 4.4%

Value ($000) $57,156 Shares 3,711,444 Est. Cost $18.70 Unrealized +6.5%

NUVL NUVALENT INC 5.6%

Value ($000) $73,186 Shares 727,563 Est. Cost $22.67 Unrealized +335.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
COGT	COGENT BIOSCIENCES INC	9,003,418	$319,801	24.3%	$9.55	+194.3%	COM	19240Q201
APGE	APOGEE THERAPEUTICS INC	2,048,647	$154,632	11.8%	$22.03	+185.9%	COM	03770N101
SYRE	SPYRE THERAPEUTICS INC	4,018,101	$131,633	10.0%	$31.80	-17.8%	COM NEW	00773J202
ORKA	ORUKA THERAPEUTICS INC	3,705,262	$112,306	8.5%	$32.55	-14.4%	COM	687604108
ELVN	ENLIVEN THERAPEUTICS INC	3,711,444	$57,156	4.4%	$18.70	+6.5%	COM	29337E102
NUVL	NUVALENT INC	727,563	$73,186	5.6%	$22.67	+335.0%	COM	670703107